Journal of Clinical and Translational Hepatology · 2018 · 28 citations · 8 references
PharmacyInfectious DiseasesInternal MedicineHepatologyMolecular VirologyVirologyAntiviral PharmacologyAntiviral TherapyInterferon-based TherapyViral ClearanceViral HepatitisViral Hepatitis TreatmentAntiviral TreatmentAspartate Aminotransferase ElevationDirect-acting Antiviral AgentsDirect-acting AntiviralsNormalizationSerum Alanine AminotransferaseSerum Aspartate AminotransferaseSustained Virologic Response Duration
Background and Aims: Hepatitis C virus (HCV) infection results in hepatocytic injury with elevation of both alanine aminotransferase (ALT) and aspartate aminotransferase (AST). It remains to be determined if direct-acting antiviral treatment can terminate hepatocytic injury following virologic response. To this end, we evaluated the pattern and predicting factors of ALT and AST normalization during and after direct-acting antiviral treatment with sustained virologic response at 12 weeks (SVR12).
8
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault, Natalie Bzowej, Kyong‐Mi Chang et al. · Hepatology · 2015 · 2K citations